In this continuation of a three-part series, the author explores the potential use of agentic AI in pharmaceutical R&D.

We need to restructure our education system –Stakeholders Our leaders don’t demonstrate they know the value of varsities ...

Doug and Polly White are small business experts, speakers and consultants who work with entrepreneurs through Whitestone ...